CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- 4 Open-market buy Director bought 20,000 shares at $0.68 ($13,578)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,007 shares (to pay taxes)
- 4 Grant or award Director acquired 16,000 shares (grant or award)
- 4 Grant or award Director acquired 16,000 shares (grant or award)
- 4 Grant or award Director acquired 16,000 shares (grant or award)
- 4 Grant or award Director acquired 16,000 shares (grant or award)
- 4 Grant or award Director acquired 16,000 shares (grant or award)
- 4/A Insider Changes in Ownership
- 4 Shares withheld for taxes SVP, Chief Scientific Officer gave up 3,902 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 3,292 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Scientific Officer gave up 47,191 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 41,094 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 39,374 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel gave up 42,972 shares (to pay taxes)
- 4 Grant or award President, Chief Exec Officer acquired 250,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 7,375 shares (grant or award)
- 4 Grant or award Director acquired 6,922 shares (grant or award)
- 4 Grant or award Director acquired 7,375 shares (grant or award)
- 4 Grant or award Director acquired 7,375 shares (grant or award)
Page 4 of 28 · 550 filings